BioSpace News Archive

-- Golodirsen has been studied for the treatment of exon 53 amenable patients, approximately eight percent of patients with Duchenne --

Pandion Therapeutics today announced it has received an investment from the JDRF T1D Fund.

According to the U.S. Centers for Disease Control and Prevention (CDC), 12 people in three states were hospitalized for infections caused by bacterial contamination of stem cell products.

Holidays mean a lot of opportunity to socialize with people both within and outside of your field, and if you happen to be on the job market or considering making a career switch in 2019, it can also be a great opportunity to make organic connections with people who may end up helping you out in the future.

BeBop Sensors, Inc. www.bebopsensors.com, the leader in smart fabric sensor technology with over two million wearable smart fabric sensors shipped, announced today that they will be exhibiting at CES 2019, Booth #50908 at the Sands, Eureka Park.

Met primary endpoint with robust statistical significance

Turning an existing partner into a wholly owned subsidiary, Novartis is acquiring CellforCure from biotechnology group LFB for an undisclosed figure.

Using a calculation, ICER believes the Novartis gene therapy for Spinal Muscular Atrophy will be more cost effective than Biogen’s Spinraza.

After enduring a deluge from multiple hurricanes earlier this year, the Carolinas are about to be flooded with something else far more preferable – jobs. Pharma companies are hiring for hundreds of positions, according to reports.

Meridian is donating $100,000 worth of coats, hats, gloves, and socks to the homeless through local shelters